Pyridine

Pyridine

SCHEMBL30058515

N=C(N)c1ccccn1.c1ccncc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
P4HTM Q9NXG6 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
KMT2A Q03164 5/20 0.46
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
PKM P14618 2/20 0.42
MITF O75030 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
MAPT P10636 1/20 0.42
CCR6 P51684 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL247847 0.92
Hydrochloric Acid SCHEMBL29535473 0.90 CES2 (0.52) LMNANAPRTP4HTML3MBTL1CES2
Water SCHEMBL27552684 0.90 CES2 (0.52) LMNANAPRTP4HTML3MBTL1CES2
Hydrochloric Acid SCHEMBL857460 0.90 CES2 (0.52) LMNANAPRTP4HTML3MBTL1CES2
Hydrochloric Acid SCHEMBL5945629 0.88 CES2 (0.50) LMNANAPRTP4HTML3MBTL1CES2
Acetic Acid SCHEMBL27680883 0.85 ALDH1A1 (0.60) LMNANAPRTP4HTML3MBTL1CES2
Maleic Acid SCHEMBL7226173 0.82 LMNA (0.53) LMNANAPRTP4HTML3MBTL1CES2
Hydrochloric Acid SCHEMBL3226020 0.81 F7 (0.46) KMT2AALDH1A1NPC1RAB9APKM
Pyrrole SCHEMBL28132369 0.81 CES2 (0.44) LMNANAPRTP4HTML3MBTL1CES2
2-Picolinic Acid SCHEMBL7562378 0.80 LMNA (0.80) LMNANAPRTP4HTML3MBTL1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076460-B1 1,4-DIHYDRO-2H-SPIRO[ISOQUINOLINE-3,4'-PIPERIDINE DERIVATIVES AS PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER MERCK SHARP & DOHME LLC (US) 2026-01-21 EP disclosed
US-12441730-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2025-10-14 US disclosed
US-20230114091-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-04-13 US disclosed
EP-4076460-A1 PRMT5 INHIBITORS Merck Sharp & Dohme LLC (US) 2022-10-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230114091-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 LMNA 1841/4885NAPRT 3080/4885P4HTM 340/4885
US-12441730-B2 PRMT5 inhibitors PRMT5, PRMT1, PRMT3 LMNA 1841/4885NAPRT 3080/4885P4HTM 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.